by Gary Miller
United States Sens. Cory Booker (D-NJ) and Elizabeth Warren (D-Mass.) have teamed up for cannabis reform. On Oct. 6, the senators sent a letter urging the Department of Justice (DOJ) to decriminalize cannabis at the federal level.
Specifically, the senators called on the U.S. attorney general, Merrick Garland, who has the right to remove substances from the controlled substances list under the Controlled Substances Act of 1970 (CSA). However, the attorney general must first work with the Secretary of Health and Human Services (HHS) to confirm that the substance has no potential for abuse.
The letter states, “Decriminalizing cannabis at the federal level via this descheduling process would allow states to regulate cannabis as they see fit, begin to remedy the harm caused by decades of racial disparities in enforcement of cannabis laws, and facilitate valuable medical research. While Congress works to pass comprehensive cannabis reform, you can act now to decriminalize cannabis.”
According to the journal Missouri Medicine, decriminalization “is the act of removing criminal sanctions against an act, article, or behavior.” While cannabis would still be federally illegal and not widely accessible for adult use, citizens would not be prosecuted by the legal system for possession under a certain amount.
In their letter, the senators called out President Joe Biden for falling short on his campaign promises to decriminalize cannabis and expunge all prior use convictions, an action supported by a majority of Americans. Based on recent statistics from Pew Research Center, approximately 91% of U.S. adults believe cannabis should be legal for either medical or recreational use.
The letter also notes that the National Institutes on Drug Abuse (NIDA) acknowledges the medical benefits of THC and CBD. “Cannabis’s Schedule I classification is a significant barrier to further medical research because researchers are severely limited in their ability to access the substance,” wrote the senators.
Booker and Warren requested a response from the attorney general by Oct. 20 on whether he will consider ordering an HHS review, which is the first step in descheduling a drug.
Bravo to Warren & Booker for pushing the issue to decriminalization cannabis! It’s time to move forward toward progress!
It’s safe to say that the wheels on the cannabis reform express have certainly been set in motion. As of April 2022, 47 states have legalized cannabis in some form or another. However, the plant’s federally illegal status—U.S. law categorizes cannabis as a Schedule I drug—means that businesses operating in this industry cannot conduct transactions with…
Cannabis’ former reputation as a gateway drug may have been dispelled, but it turns out that there is some element of truth to the rumor: The plant’s progressively evolving status as a normalized medicine in 37 U.S. states and a recreational substance in 18 U.S. states is prompting a wave of change across America’s statehouses….
Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. Nicknamed “K,” “special K,” “cat valium,” and “vitamin K,” ketamine is…
Austin decriminalized cannabis possession, Vancouver is now home to some not-so-legal magic mushroom shops, and a British woman shared her life-changing medical marijuana journey. Let’s dive into this week’s cannanews. Austin Voters Pass Cannabis Decriminalization Bill Voters in Austin, Texas, have approved Proposition A, a ballot measure that decriminalizes cannabis possession and bans no-knock warrants….
Cannabis strains have a multitude of different names. The names are a way to help identify different varieties of cannabis genetics. The name of a specific line of cannabis genetics should help identify the strain for consumers and growers alike. However, this isn’t necessarily true anymore. We live in an era where people will call…
The worldwide skincare industry, which is projected to inflate to $189.3 billion USD by 2025, could soon be merging more closely with…
There’s no denying the fact that CBD is dominating the wellness landscape. Increasing awareness of the cannabinoid’s medicinal effects is going hand-in-hand…
As if losing a limb is not hard enough, experiencing pain in the part of the limb that is no longer there…
